BRAF and thyroiditis: Mendelian randomization (MR) and molecular docking were used to validate causal genes and potential drug interactions.<h4>Results</h4>PTC-blank exhibited higher T, N, and M stages and increased mutations in BRAF and MUC16 compared to PTC-thyroiditis.